Search research articles
Contact Us
Filters
Showing results (161-170 of 275) with videos related to
Page
of 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
February 28, 2024
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations
David S Hong, Federico Cappuzzo, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer
Rafal Dziadziuszko, Samir E Witta, Federico Cappuzzo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 27, 2024
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy
Felice Musicco, Chiara Fulgenzio, Antonia La Malfa, et al.
The New England Journal of Medicine
|
December 4, 2014
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
Benjamin J Solomon, Tony Mok, Dong-Wan Kim, et al.
Recenti Progressi in Medicina
|
July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]
Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Frontiers in Surgery
|
July 19, 2021
Nodal Upstaging Evaluation After Robotic-Assisted Lobectomy for Early-Stage Non-small Cell Lung Cancer Compared to Video-Assisted Thoracic Surgery and Thoracotomy: A Retrospective Single Center Analysis
Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 12, 2022
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
Kai Guo, Zhiqiang Ma, Yujiao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
Lucio Crinò, Federico Cappuzzo, Petr Zatloukal, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 29, 2026
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies
Mauricio Burotto, Zanete Zvirbule, Renzo Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial
Federico Cappuzzo, Claudia Ligorio, Pasi A Jänne, et al.
Page
of 28
Search research articles
Search
Showing results (161-170 of 275) with videos related to
Sort By:
Page
of 28
Lung Cancer (Amsterdam, Netherlands)
|
February 28, 2024
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations
David S Hong, Federico Cappuzzo, Byoung Chul Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2006
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer
Rafal Dziadziuszko, Samir E Witta, Federico Cappuzzo, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 27, 2024
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy
Felice Musicco, Chiara Fulgenzio, Antonia La Malfa, et al.
The New England Journal of Medicine
|
December 4, 2014
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
Benjamin J Solomon, Tony Mok, Dong-Wan Kim, et al.
Recenti Progressi in Medicina
|
July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]
Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Frontiers in Surgery
|
July 19, 2021
Nodal Upstaging Evaluation After Robotic-Assisted Lobectomy for Early-Stage Non-small Cell Lung Cancer Compared to Video-Assisted Thoracic Surgery and Thoracotomy: A Retrospective Single Center Analysis
Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 12, 2022
HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway
Kai Guo, Zhiqiang Ma, Yujiao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study
Lucio Crinò, Federico Cappuzzo, Petr Zatloukal, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 29, 2026
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies
Mauricio Burotto, Zanete Zvirbule, Renzo Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial
Federico Cappuzzo, Claudia Ligorio, Pasi A Jänne, et al.
Page
of 28